Globus Medical (GMED) Net Cash Flow (2011 - 2026)

Globus Medical (GMED) has reported Net Cash Flow for 16 consecutive years, with -$53.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow rose 78.14% year-over-year to -$53.8 million; the trailing twelve-month figure through Jun 2026 stood at $276.2 million (up 239.05% YoY), and the FY2025 full-year result was -$280.7 million, down 188.59% from the prior year.
• Net Cash Flow eased to -$53.8 million in Q2 2026 per GMED's latest filing, from $37.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $208.3 million in Q3 2024 and bottomed at -$326.7 million in Q1 2025.
• Historically, Net Cash Flow has averaged $16.3 million across 5 years, with a median of $37.4 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 1000.68% in 2023, then tumbled 568.12% in 2025.
• Over 5 years, Net Cash Flow stood at $17.1 million in 2022, then surged by 1000.68% to $188.0 million in 2023, then declined by 11.74% to $166.0 million in 2024, then fell by 9.4% to $150.4 million in 2025, then slumped by 135.78% to -$53.8 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$53.8 million, $37.9 million, and $150.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.